This blog post is not an argument for reductionism. Instead, it is an argument for speeding up treatments that work in the case of a complex disease like aging. While demand for such treatments exists, anti-aging clinical trials are extremely rare. Elderly patients are the most complex ones of all – it is what intellectually…… Continue reading How to divide and conquer aging by tackling rare diseases